• Explore /
  • Poster
  • / Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: A randomized, placebo controlled, phase III trial—SAFE trial.

Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: A randomized, placebo controlled, phase III trial—SAFE trial.

Abstract Poster

Authors

Icro Meattini

Icro Meattini

Florence University, Florence, Italy

Icro Meattini , Roberto Tarquini , Calogero Saieva , Alice Valoriani , Pierluigi Bonomo , Isacco Desideri , Mauro Loi , Vieri Scotti , Carla De Luca Cardillo , Stefano M. Magrini , Gianfranco Gensini , Lorenzo Livi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT2236806

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS1100)

DOI

10.1200/jco.2015.33.15_suppl.tps1100

Abstract #

TPS1100

Poster Bd #

214a

Abstract Disclosures

Similar Posters

First Author: Lorenzo Livi

First Author: Venkatraman Radhakrishnan

First Author: Douglas W. Blayney

First Author: Pamela N. Munster